Stocks Slip Ahead of Fed Meeting as Treasury Yields Tick Up | The Close 11/8/2025

Markets are cautious ahead of Wednesday's Fed meeting as 10-year Treasury yields have risen to ~4.17% (highest since September) despite widespread expectations of a 25bp cut, highlighting tension between easing policy bets and sticky inflation/labor data. Key corporate developments include Paramount/SkyDance's hostile $108bn bid for Warner Bros. Discovery amid Netflix interest, IBM's $9.3bn acquisition of Confluent to bolster enterprise AI data pipelines, and a reported Medline IPO targeting $5.37bn; geopolitically sensitive trade policy moves saw the U.S. agree to allow NVIDIA to export H200 chips to China (excluding highest-end Blackwell models) with administration revenue-sharing discussed. The program flagged private-market AI FOMO, leadership shifts at Berkshire (and Todd Combs' move to JPMorgan), and mixed retail signals (7–11% foot-traffic gains at top malls), all reinforcing a higher-volatility, event-driven market backdrop for positioning.

Analysis

Market structure: The immediate winners are AI/semiconductor beneficiaries (NVDA) and enterprise data players (IBM/CFLT) as M&A and export relief re‑rate demand for chips and real‑time data plumbing; media assets (WBD) become take‑over lottery tickets benefiting opportunistic cash bidders (Paramount) while strategic/stock bidders (NFLX) face dilution risk. Bond market has decoupled from front‑end Fed easing: 10y ~4.17% and curve steepening signal tighter real rates and higher risk premia, pressuring high multiple growth names and boosting financials/cash‑flow defensives.

Risks: Tail risks include (1) a Fed pause/no‑cut Wednesday triggering a 5–15% equity repricing within days; (2) regulatory blowups — U.S. export terms (the reported 25% revenue share) or antitrust blocks on WBD deals — that could vaporize expected synergies; (3) private‑credit repricing leading to visible defaults over 3–12 months. Hidden dependencies: liquidity in secondary private markets and Treasury supply dynamics are amplifiers; inflation/tariff pass‑through could keep rates elevated into 2026.

Trade implications: Near term (days–weeks) favor skewed, event‑aware option exposure: buy 3–9 month call spreads on NVDA and 6–12 month call spreads on IBM to capture AI/strategic M&A optionality while funding with small shorts or call overwrites. Rotate 3–9% portfolio weight from US mega‑cap momentum into small‑cap cyclicals/European exporters (IWM, VGK) and ballast with longer‑dated corporate credit selectively. Hedge macro risk with Jan‑2026 7–10% OTM SPY put spreads sized 1–2%.

Contrarian angle: Consensus assumes swift Fed easing and perpetual AI multiple expansion; markets are under‑pricing policy and regulatory binary risk. If export terms are narrowed or legal challenges arise, NVDA upside compresses quickly — making disciplined entry on 5–10% pullbacks or post‑final Commerce text the higher‑probability trade. Conversely, WBD cable spin‑offs may be underpriced if leverage is limited — selective event arbitrage could pay off if regulatory bias favors a cash bidder.

Key Decisions for Investors

• Establish a 2–3% portfolio long in NVDA via a 3–6 month call spread (buy slightly ITM / sell 20–30% OTM) or buy stock on a 5–10% pullback; entry trigger: final Commerce export guidance published — if the H200 permission is confirmed, add; sell into any 20%+ pop.
• Add a 1.5–2.5% position in IBM using a 9–12 month call spread to capture Confluent synergies; tranche in over 2 buys (now and on any <5% pullback) and target 20–30% upside over 12 months before reassessing.
• Open a tactical 1–2% short/put position in NFLX (buy 3‑month 5–10% OTM puts or short stock) anticipating deal dilution and investor fatigue; cover/exit if NFLX closes >5% above current levels on clear deal path or WBD acceptances >$32.
• Implement macro insurance: buy Jan‑2026 SPY 7–10% OTM put spread sized 1–2% of portfolio (cost‑fund with call overwrites on winners) to protect against a Fed no‑cut shock or sharper bond selloff over the next 3 months.
• Rotate 3–5% from US mega‑cap momentum into small‑cap and European exposure: allocate to IWM (1.5–2.5%) and VGK/IEV (1–2%) over next 4–8 weeks to capture potential re‑rating if global capex and commodity demand broaden; trim if 10y falls below 3.9%.